Well, I'd be surprised if non-R&D inference providers were selling at a loss. There are a plethora to choose from, competition is quite healthy. Will they keep providing cheap tokens while the labs raise their prices? Probably, but then I don't see how they could be raised in the first place. And what timescale are you talking about? A couple of years? It is appropriate to assume inference will become more efficient over time. If you raise your prices, you are going to be out competed before it's profitable (if you assume it is unprofitable) which would be negligent. I don't see how this makes sense.